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INTRODUCTION
Menopause is the cessation of menstruation for more than 1 
year, owing to depletion of ovarian function.1 As the life expec-
tancy of women has increased, presently, approximately one-
third of a woman’s life is postmenopausal. Women experience 
several postmenopausal symptoms, and management of these 
symptoms is crucial for maintaining their quality of life. Vaso-
motor symptoms, insomnia, vaginal dryness, and other such 
symptoms are associated with the postmenopausal period, and 
they can impair woman’s normal function and well-being.2 Hor-
mone therapy (HT) is the most effective treatment for severe 
postmenopausal symptoms.3,4 However, there are several other 
non-hormonal treatment options, such as health functional 
foods, oriental medicine, and relaxation therapy. After the 
Women’s Health Initiative (WHI) study, there has been some 
confusion about whether women experiencing menopausal 
symptoms should utilize HT.5 Many women have opted for non-
hormonal treatments, such as health functional foods, relax-
ation therapy, exercise, or diet. Nevertheless, the effects of these 
non-hormonal treatments are not as promising as those of HT.6
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There have been several trials worldwide in finding out the 
middle-aged women’s perception of menopause and its treat-
ment methods. A Belgian study used an internet survey to ob-
tain information from 600 postmenopausal women. Almost all 
participants (98%) were aware of menopause, and 82% knew 
the different treatment options. Interestingly, HT was used sig-
nificantly more often by French-speaking women (32%) than 
by Dutch-speaking women (9%).7 On the other hand, a Chinese 
study has shown that HT awareness among women was only 
3.5% and that, although most Chinese women had knowledge 
of menopause, they thought menopausal symptoms should 
not be treated.8 A study from Central America reported that 
women considered HT as a treatment option in 27.2%, but the 
actual use was rather low (2.7%).9 Different cultures and socio-
economic backgrounds are reflected in the different results in 
these studies. Due to this background, the present study aimed 
to investigate the perceptions of postmenopausal symptoms 
and treatment options among Korean middle-aged women.
MATERIALS AND METHODS
This study was done during the “2015 Cool Diva campaign” su-
pervised by the Korean Menopause Society. The study enrolled 
2330 Korean women aged 45–65 years. ‘Middle-aged’ women 
are defined as women in their perimenopausal and postmeno-
pausal period, and 45–65 years of age is the correlated period. 
The participants included menopausal (45.1%) and perimeno-
pausal women. After stratified sampling, random quota sam-
pling of the participants was performed. Sociodemographic 
data, such as age, education level, resident city, occupation, 
and income, were collected. This study used asmartphone sur-
vey application (http://ovey.co.kr) with a structured question-
naire composed of 21 questions with regard to the following 
three categories: general perceptions of menopause, treatment 
options, and postmenopausal symptoms and their treatments. 
The survey was conducted for 3 days from June 16 to 19, 2015. 
The study subjects randomly participated the mobile survey 
at their own will and were rewarded with an item they chose 
after they finished the survey. The survey was automatically 
finalized once the number of participants reached 2330. The 
study was performed according to the tenants of the Declara-
tion of Helsinki and was approved by the Institutional Review 
Board of Yonsei University Health System, Severance Hospital 
(4-2015-0756).
The first questionnaire category (general perceptions of 
menopause) included questions on whether the study partici-
pants perceived menopause as a disease. It also included ques-
tions on the source of information about menopause. The sec-
ond category (treatment options) had the following three topics: 
HT, health functional foods, and visiting gynecology clinics. 
The study participants were asked whether they were aware 
about HT or health functional foods and their opinion on these 
treatments. They were also asked whether they had visited gy-
necology clinics for postmenopausal symptoms and if they 
were inclined to visit such clinics in the future. The third catego-
ry (postmenopausal symptoms and their treatments) included 
questions on whether the participants experienced certain 
postmenopausal symptoms and whether they tried to improve 
the symptoms. It also included questions on the approaches to 
handle the symptoms and the effectiveness of the treatment 
approaches. Finally, the participants were questioned on 
whether they had discontinued HT previously and on the rea-
sons for discontinuing HT. Statistical analysis was done using 
Pearson’s chi-square test by SPSS ver. 23 (IBM, Armonk, NY, 
USA).
RESULTS
The sociodemographic characteristics of the study partici-
pants are presented in Fig. 1. Approximately 70% of the study 
participants were aged 45–54 years and lived in Seoul (the cap-
ital of Korea) or nearby Gyeonggi province. Additionally, ap-
proximately 50% were working, 40% were homemakers, and 
more than 60% had college education.
With regard to the first questionnaire category (general per-
ceptions of menopause), 65% of the participants recognized 
menopause as a disease that needs treatment. The perception 
of menopause as a disease was greater in younger participants 
than in older participants (70.5% for participants in their late 
40s, and 56.7% for participants in their early 60s). Participants 
who had high income had a tendency to recognize menopause 
as an illness (72.5%) (Supplementary Table 1, only online).
For obtaining information about menopause, a majority of 
participants (64.6%) depended on their friends or family mem-
bers, and many relied on mass media, such as TV/radio (50.5%) 
and the internet/social network services (SNS) (45.0%). High 
proportions of participants, especially in their late 40s (50.7%) 
and early 50s (44.3%), obtained information from the internet/
SNS (Supplementary Table 2, only online).
With regard to the second category (treatment options), 
66.8% of the participants were aware that HT is available for 
menopausal symptom treatment. Awareness about HT was 
greater among participants in their early 60s than among those 
in their late 40s (81.9% vs. 63.9%) and greater among partici-
pants with high income than among those with low income 
(72.5% vs. 58.0%). Moreover, awareness about HT was higher 
among participants who considered menopause as a disease 
than among those who did not consider menopause as a dis-
ease (70.7% vs. 59.6%) (Supplementary Table 3, only online).
A low proportion of participants had positive views about 
HT (30.9%), and most participants had neutral views (61.7%). 
A very low proportion of participants had negative views about 
HT (7.3%). Among participants in their late 40s, 33.0% had posi-
tive views, and among participants in their early 60s, 69.4% 
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had neutral views about HT. Participants who perceived meno-
pause as a disease had more positive views about HT (40.7%) 
than those who did not (Supplementary Table 4, only online). 
The most common reasons for having negative views about HT 
were its adverse reactions (47.3%) and concerns about devel-
oping cancer (41.1%) (Supplementary Table 5, only online). 
For alleviating menopausal symptoms, 42.8% of the partici-
pants believed that simple lifestyle modifications would be ef-
fective, while 30.2% and 14.7% believed that HT and health 
functional foods would be effective, respectively (Table 1) (Sup-
plementary Table 6, only online). Low proportion of partici-
pants (29.9%) visited clinics for professional consultation and 
treatment (Supplementary Table 7, only online). The lowest 
proportion was noted for participants in their late 40s (19.6%), 
and with age, the proportion of participants who sought pro-
fessional help increased (early 50s, 35.5%; late 50s, 40.4%; ear-
ly 60s, 43.3%). Moreover, clinic visits were more common 
among participants who considered menopause as a disease 
than among those who did not consider menopause as a dis-
ease (35.8% vs. 18.9%). The participants’ willingness to visit 
Fig. 1. Sociodemographic data of the study population.
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clinics in the future and the reason for avoiding the clinics are 
described more in Supplementary Table 8 and 9 (only online).
With regard to the third category (postmenopausal symptoms 
and their treatments), 70.8% of the menopausal participants ex-
perienced menopausal symptoms (Supplementary Table 10 
and 11, only online). Among the symptoms experienced, hot 
flushes were the most common (75.4%), followed by vaginal 
dryness (50.9%), fatigue (50.3%), and insomnia (47.6%) (Table 2) 
(Supplementary Table 12, only online). The menopausal symp-
tom that was the most difficult to endure was hot flushes 
(33.1%), followed by insomnia (15.1%) and arthritic or muscular 
pain (9.2%) (Supplementary Table 13, only online). Although 
the most frequently experienced symptoms were vaginal dry-
ness and fatigue, they were not considered difficult to endure by 
Table 1. Treatment Options that are Considered to be Helpful for Alleviating Menopausal Symptoms
All
Age (yrs)
p value*
45–49 50–54 55–59 ≥60
Number of participants 2330 1028 690 485 127
Lifestyle modifications (%) 42.8 41.5 45.5 40.4 47.2 0.201
Clinic visit or HT (%) 30.2 33.1 26.8 29.1 29.1 0.035
Health functional foods (%) 14.7 14.1 15.7 15.5 11.0 0.372
None (%) 6.7 5.4 6.7 9.3 7.9 0.038
Oriental medicine (%) 3.6 3.8 3.0 3.9 3.9 0.773
Phytoestrogens (%) 1.7 1.7 2.2 1.4 - 0.465
Others (%) 0.3 0.4 0.1 0.4 0.8
Total 100.0 100.0 100.0 100.0 100.0
HT, hormone therapy.
*Pearson’s chi-square test.
Table 2. Experienced Postmenopausal Symptoms
Multiple choices All
Age (yrs)
p value*
45–49 50–54 55–59 ≥60
Number of participants 743 88 294 283 78
Vasomotor symptoms (%) 75.4 79.5 74.5 76.0 71.8 0.767
Vaginal dryness (%) 50.9 47.7 54.8 49.5 44.9 0.288
Fatigue (%) 50.3 55.7 54.4 46.3 43.6 0.115
Insomnia (%) 47.6 46.6 51.4 47.0 37.2 0.162
Palpitation (%) 42.0 47.7 41.2 38.9 50.0 0.258
Depression (%) 40.6 47.7 40.5 38.9 39.7 0.615
Temperament (%) 38.6 43.2 42.5 35.7 29.5 0.106
Arthritic/muscular pain (%) 37.7 39.8 42.2 35.7 25.6 0.028
Perspiration (%) 35.7 36.4 39.1 33.9 28.2 0.224
Dizziness (%) 18.2 22.7 19.0 17.3 12.8 0.352
Headache (%) 16.8 27.3 17.0 13.8 15.4 0.031
*Pearson’s chi-square test.
Table 3. Attempted Treatments by the Participants
All
Age (yrs)
p value*
Menopause as 
a disease p value*
45–49 50–54 55–59 ≥60 Yes No
Number of participants 743 88 294 283 78 487 256
Diet and exercise (%) 36.5 33.0 35.7 39.2 33.3 0.615 30.8 47.3 <0.001
Clinic visits and HT prescription (%) 19.7 19.3 16.3 20.5 29.5 0.073 26.3 7.0 <0.001
Health functional foods (%) 11.4 13.6 13.6 10.2 5.1 0.155 12.5 9.4 0.2
Clinic visits and non-hormonal treatment prescription (%) 10.5 14.8 12.6 7.8 7.7 0.113 14.4 3.1 <0.001
Etc. (%) 3.0 2.3 3.4 3.2 1.3 2.9 3.1
None (%) 19.0 17.0 18.4 19.1 23.1 0.768 13.1 30.1 <0.001
HT, hormone therapy.
*Pearson’s chi-square test.
537
Min Kyoung Kim, et al.
https://doi.org/10.3349/ymj.2017.58.3.533
many participants (8.3% and 7.5%, respectively).
Table 3 shows the actually attempted treatment options by 
the survey participants (Supplementary Table 14 and 15, only 
online). Once again, the highest number of women tried life-
style modifications, such as diet and exercise (36.5%), and HT 
was the second popular choice (19.7%). The comparisons be-
tween the groups perceiving menopause as a disease or not 
show significant differences. People who perceived menopause 
as a disease visited clinics and used HT or non-hormonal treat-
ments more than the counterpart. On the other hand, those 
who did not think menopause as a disease tended to do noth-
ing for treatment.
Among the participants who used HT, a high proportion of 
participants stopped using HT (78.1%) (Supplementary Table 
16, only online). The main reasons for discontinuation of HT 
were concerns about developing cancer (36.8%) and experi-
encing adverse reactions (23.7%) (Supplementary Table 17, 
only online).
DISCUSSION
This study demonstrated the current state of perceptions of Ko-
rean women with regard to postmenopausal symptoms and 
their management. A relatively large number of participants 
recognized menopause as a disease that needs treatment and 
obtained information from friends/family members and the in-
ternet or social media rather than from professionals. Many 
participants preferred lifestyle modifications or health func-
tional foods to HT and believed that these approaches could al-
leviate menopausal symptoms. Additionally, participants who 
used HT but discontinued treatment were mostly worried 
about developing cancer and experiencing adverse reactions.
The results of previous epidemiological studies on the aware-
ness of menopause among Korean menopausal women per-
formed by the Korean Menopause Society10-12 are comparable 
to the results of our study. Although the study population dif-
fered among the previous studies and our study, with regard 
to the number of participants and age groups, the finding that 
more than half of the participants knew about HT was similar. 
On the other hand, the percentage of actual users of HT de-
creased from 24.3% in the year 200211 to less than 20% in this 
study. It is quite discouraging to find that HT utilization has 
not increased among postmenopausal women, although more 
than a decade has passed since the announcement of the pre-
vious studies. However, the HT awareness rate is not so low 
when compared to studies from other countries. A Pakistan 
study showed that only 5% of the participants had knowledge 
about HT even though the study population included highly 
educated Asian women.13 A recent Belgian study revealed 16% 
of 696 postmenopausal women were using HT.7 The Central 
American women also showed low percentage; 10.2% were 
currently using HT, whereas 13.8% previously used HT but ab-
andoned it.9 Therefore, compared to these reports from around 
the world, about 20% of Korean women using HT do not seem 
to be lagging behind.
The present study differs from previous reports11,12 by the Ko-
rean Menopause Society in several aspects: first, this was the 
largest study, including over 2300 women, whereas previous 
studies had 1201 participants. Second, it was the first attempt to 
utilize a mobile application survey, whereas previous studies 
were done by face-to-face interviews or answering question-
naires on paper. Third, the results of a 2002 study showed that 
53.6% perceived HT as a treatment option, and the present 
study showed an increased percentage of women who knew of 
HT (65.6%). Obviously, people had easier access to information 
about HT these days than in the past. Additionally, the most 
common reason for stopping HT in the past was the adverse ef-
fects of HT, whereas in the present it was the fear of getting can-
cer. This result also demonstrates that women today receive 
various sources of indiscriminate information about HT and 
the risk of cancer.
Many Korean women believed that their menopausal symp-
toms could be effectively treated with lifestyle modifications, 
such as diet and exercise. Some women had the false idea that 
HT is detrimental to the body’s natural system.11,12 Although 
there was no significant difference among different age groups, 
it was also evident from this study that the primarily considered 
treatment option among Korean women was lifestyle modifica-
tion. Therefore, health care professionals in Korea should edu-
cate women and their family members about the benefits of HT 
and that it is more effective than lifestyle modification.
Koreans have easy access to the internet and mass media, 
and this development of information technology in Korea has 
resulted in greater knowledge about menopause and its treat-
ments among Korean women than women from other coun-
tries. A previous Chinese study8 reported that HT awareness 
among Chinese women was only 3.5%, and another study from 
Central America9 reported it was 27.2%. However, in our study, 
the proportion of women who were aware of HT was 66.8%. Al-
though a high number of Korean women were aware about HT, 
the actual number of HT users was not as high as that of wom-
en perceiving HT, which indicates that information technology 
has some limitations. Our study found that younger middle-
aged women in their late 40s and early 50s were avid users of 
the internet and mass media and that these were the primary 
sources for information about menopause. However, regardless 
of easy access to abundant information about menopausal 
treatments via the internet or mass media, the most common 
treatment method chosen by most women was still ‘lifestyle 
modification’.
After the publication ofthe WHI study,14-17 which was over-
stated in mass media, many individuals became concerned 
about the breast cancer risk associated with HT, and the num-
ber of HT users consequently decreased. The current study 
found that women tend to think negatively about HT because 
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of the possible risk of breast cancer. However, a follow-up WHI 
study showed that the incidence of breast cancer was not 
greatly influenced by HT, and the combined estrogen-proges-
terone therapy group was shown to have an increase in the in-
cidence rate by only <1.0 per 1000 women per year of use.18-20 
This demonstrates that the initial findings were exaggerated 
by mass media, which considerably affected public judgment. 
There are many treatment options in HT and new approach-
es, such as tissue-selective estrogen complex, have been in-
troduced to reduce the risk of breast cancer.21,22 Many women 
are not aware that there are definite contraindications and in-
dications for appropriate HT usage and that not everyone has 
the same risks or treatment criteria. The public should be in-
formed that consultations with physicians are important to 
ensure appropriate and effective treatment.
The present study has some strengths. First, this study had a 
large population that included women from various back-
grounds (e.g., different areas of living, occupations, and educa-
tion levels). This is the most up-to-date and largest study in a 
single Asian country. With this representative data, we hope to 
realize the current status and plan for improvements in any de-
ficiencies found. Second, selection bias was reduced owing to 
the random selection of participants. Third, the study question-
naires were systematically categorized, and this facilitated a 
deeper understanding of the study topic.
On the other hand, this study also had some limitations. 
Since this was a mobile survey without much further assistance 
or guidance by the survey organizer, some questionnaires may 
have been skipped or not answered properly by the partici-
pants. Also, the data were collected by a smartphone applica-
tion that only the people who knew this application or were 
able to use such program participated. Over 60% of the partic-
ipants had high education levels, and thus, we may need to be 
careful in interpreting this as the perception of the general 
Korean population. However, subanalysis according to educa-
tion level also showed similar results to the main results of this 
study. As previously described, a high percentage of the Kore-
an public obtains information about HT through mass media 
or internet. Also, since medicine is such a professional field, 
the differences in perception of postmenopausal treatments 
among various education levels seem to be less likely. Further-
more, as this study had a cross-sectional design, the causality 
of the women’s perspectives of HT and socioeconomic or cul-
tural factors could not be determined. Further studies will be 
needed to assess these aspects.
In conclusion, while high numbers of Korean women were 
aware about HT, relatively few women selected HT for the treat-
ment of menopausal symptoms, possibly because of informa-
tion obtained from the internet/mass media and false beliefs 
about the negative effects of HT. There is a need to improve 
public awareness of the benefits of HT. Medical professionals 
will need to educate the public on treatments for menopausal 
symptoms, and measures should be taken to remove incorrect 
information from the internet/mass media.
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